Executive Summary
January 20, 2026, saw 48 neutral 8-K filings, highlighting clusters of executive changes (10+ companies), financial results disclosures (10+ firms, especially banks), and material definitive agreements (10+ entities), indicative of quarter-end housekeeping and early earnings momentum rather than seismic shifts. The pervasive lack of specific details tempers enthusiasm, but patterns suggest stable leadership transitions and deal activity without systemic distress. Portfolio managers should prioritize banking sector health and M&A follow-ups for incremental alpha, as cumulative low-medium risks point to a quiet market day with no broad sell signals.
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from January 15, 2026.
Investment Signals(5)
- Netflix/Material Agreement↓(BULLISH)▲
Entry into undisclosed material definitive agreement signals potential content or partnership expansion in competitive streaming landscape
High-materiality Item 1.01 filing suggests strategic deal-making amid media consolidation trends
- ▲
Multi-item earnings release with large 9MB filing implies comprehensive updates, potentially stabilizing regional banking peers
- Comerica Inc/Financial Results↓(NEUTRAL)▲
Item 2.02 disclosure alongside Reg FD positions it as early indicator for banking sector Q4 performance
- 3M CO/Financial Results↓(NEUTRAL)▲
Major industrial firm's results filing offers broad market sentiment gauge
Risk Flags(4)
High-risk undisclosed merger details under Item 8.01 raise execution and valuation uncertainty
Multi-item filing with undisclosed acquisition, financial obligations, and equity sales amplifies opacity concerns
- Officer Turnover Cluster/Governance Risk▼
10+ firms (e.g., KeyCorp, Otis Worldwide, SharkNinja) report Item 5.02 changes without reasons or succession plans, signaling potential leadership instability
High-risk Item 1.01 lacks terms or counterparties, critical for biotech pipeline assessment
Opportunities(4)
Item 1.01 combined with Reg FD disclosure presents upside from potential biotech partnership or financing
High 7/10 materiality Item 2.02 filing could reveal crypto operational improvements for digital asset exposure
Undisclosed Item 1.01 offers entry point into energy storage if deal unlocks growth
Multi-item filing (agreement, obligations, equity sales) positions for health tech turnaround play
Sector Themes(3)
- Banking Earnings Kickoff◆
Cluster of disclosures from Comerica, KeyCorp, Fifth Third Bancorp, US Bancorp signals Q4 results wave; monitor net interest margins amid rate environment for sector rotation
- Executive Turnover Surge◆
Over 10 firms (e.g., Peoples Bancorp, Velocity Financial, Magnachip) filing Item 5.02 indicates broad leadership refresh, potentially catalyzing strategic pivots but raising short-term governance risks
- M&A Momentum Building◆
10+ Item 1.01 filings (Netflix, Warner Bros., RAPT) point to heightened deal activity across media, biotech, and industrials, favoring acquirers in consolidation plays
Watch List(4)
Oversized filings (9-12MB) demand review for regional banking trends and deposit/loan metrics
- Netflix & Warner Bros. Discovery👁
Material agreements require exhibit scrutiny for media sector M&A or partnership details
SPAC-related mergers with high risk; track announcements for target reveals and valuations
- Banking Cluster (Comerica, KeyCorp)👁
Cross-reference financial results for correlated interest rate sensitivity and credit risk signals
Filing Analyses(48)
20-01-2026
Peoples Bancorp Inc filed an 8-K on January 20, 2026 (AccNo: 0000318300-26-000026, Size: 5 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the officer, position, reason, or financial metrics are provided in the summary. Sector is not specified.
20-01-2026
Bakkt Holdings, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015873, Size: 211 KB), reporting under Item 2.02: Results of Operations and Financial Condition, Item 8.01: Other Events, and Item 9.01: Financial Statements and Exhibits. This is a multi-item filing disclosing financial results. No specific numerical financial metrics, transaction values, or detailed outcomes are mentioned.
20-01-2026
MODIV INDUSTRIAL, INC. filed a Form 8-K on January 20, 2026 (AccNo: 0001140361-26-001557), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers (Item 5.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details, transaction values, or quantitative data disclosed in the provided summary. Sector is not specified.
20-01-2026
News Corp filed a Form 8-K on January 20, 2026 (AccNo: 0001564708-26-000012, Size: 401 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
20-01-2026
Wellgistics Health, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001493152-26-002690, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing classified as a Material Event. No specific transaction details, dollar values, parties, share counts, or financial metrics are disclosed.
20-01-2026
Hyperscale Data, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001214659-26-000614, Size: 241 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided filing summary.
20-01-2026
Dominion Energy, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015866, Size: 158 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or named entities beyond the filer are disclosed in the provided filing summary. This is a multi-item voluntary disclosure filing with no quantitative data mentioned.
20-01-2026
Avadel Pharmaceuticals PLC filed a Form 8-K on January 20, 2026, under Item 8.01 Other Events. Accession number: 0001104659-26-004698, file size: 208 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
20-01-2026
Company filed a Form 8-K on 2026-01-20 (AccNo: 0001193125-26-015864, Size: 147 KB) under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Event type is General Filing from US SEC source. No specific event details, transaction values, or financial metrics disclosed in the provided filing summary; sector not specified.
20-01-2026
Innventure, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001140361-26-001545, Size: 233 KB) reporting Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial impacts, or other specifics are provided in the filing summary. Sector is not specified.
20-01-2026
DBV Technologies S.A. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015592, Size: 301 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector not specified. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.
20-01-2026
Versus Systems Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001213900-26-005292, size 299 KB), disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no further details on the agreement, personnel changes, or exhibits provided in the summary. Sector not specified.
20-01-2026
NeoVolta Inc. filed an 8-K on January 20, 2026 (AccNo: 0001683168-26-000380, Size: 747 KB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, financial impacts, or transaction values are provided in the summary. Sector is not specified.
20-01-2026
Soren Acquisition Corp. filed an 8-K on January 20, 2026 (AccNo: 0001213900-26-005287, size: 452 KB) disclosing a merger/acquisition event under Item 8.01 Other Events, with Item 9.01 Financial Statements and Exhibits. No details on deal structure, parties, valuation, or terms are provided in the filing summary. Sector is not specified.
20-01-2026
Velocity Financial, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015556, Size: 200 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
20-01-2026
GBank Financial Holdings Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015554, Size: 235 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the financial statements/exhibits are provided in the filing summary. Sector is not specified.
20-01-2026
New ERA Energy & Digital, Inc. filed an 8-K on January 20, 2026 (AccNo: 0001213900-26-005330, Size: 699 KB), disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on deal structure, parties, valuation, or strategic rationale are provided. Sector not specified.
20-01-2026
RAPT Therapeutics, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015882, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, or exhibits provided in the summary. Sector not specified.
20-01-2026
SOMNIGROUP INTERNATIONAL INC. filed a Form 8-K on January 20, 2026 (AccNo: 0001206264-26-000002, Size: 163 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the filing summary. Core content of the disclosure is NOT_DISCLOSED.
20-01-2026
Columbus McKinnon Corp filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015918), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with no specified numerical values or named entities beyond the company itself.
20-01-2026
3M CO filed a Form 8-K on January 20, 2026 (AccNo: 0000066740-26-000003, size 1 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a financial results disclosure from the US SEC. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.
20-01-2026
Comerica Inc filed an 8-K on January 20, 2026 (AccNo: 0000028412-26-000007, Size: 762 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.
20-01-2026
NIOCORP DEVELOPMENTS LTD filed a Form 8-K on January 20, 2026 (AccNo: 0001539497-26-000076, size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. All quantitative and qualitative event details are NOT_DISCLOSED.
20-01-2026
Rockwell Medical, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001628280-26-002478), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure from the US market with file size 181 KB. No specific financial metrics, transaction details, or numerical values are mentioned in the provided filing summary.
20-01-2026
KeyCorp (/NEW/) filed an 8-K on January 20, 2026 (AccNo: 0000091576-26-000006), disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position, appointment/resignation, reasons, or quantitative financial metrics are provided in the filing summary. Sector is not specified.
20-01-2026
Fifth Third Bancorp filed an 8-K on January 20, 2026 (AccNo: 0000035527-26-000013, Size: 9 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results. No specific quantitative financial metrics, transaction values, or detailed outcomes are mentioned in the provided filing summary.
20-01-2026
US BANCORP \DE\ filed an 8-K on January 20, 2026 (AccNo: 0000036104-26-000005, Size: 12 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market. No specific financial metrics, transaction details, or quantitative data are mentioned.
20-01-2026
Trinseo PLC filed an 8-K on January 20, 2026 (AccNo: 0001104659-26-004782, size 154 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or compensation are provided in the summary. Sector is not specified.
20-01-2026
Magnachip Semiconductor Corp filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015926, Size: 172 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's position, name, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
20-01-2026
Otis Worldwide Corp disclosed an officer change via Form 8-K filed on 2026-01-20 (AccNo: 0001140361-26-001569, Size: 1 MB). The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, position, appointment/resignation status, reason, or compensation are provided.
20-01-2026
Warner Bros. Discovery, Inc. filed an 8-K on January 20, 2026 (AccNo: 0001193125-26-015949, Size: 2 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No details on the agreement, disclosures, or exhibits are provided in the available information. Sector is not specified.
20-01-2026
Netflix Inc filed an 8-K on January 20, 2026 (AccNo: 0001193125-26-015951, Size: 2 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, financial impacts, or other specifics are provided in the filing summary. Sector not specified.
20-01-2026
QXO, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001104659-26-004793, Size: 505 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the summary. Sector not specified.
20-01-2026
Chewy, Inc. disclosed an Item 5.02 event on Form 8-K filed January 20, 2026 (AccNo: 0001193125-26-015958, Size: 132 KB), regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or quantitative data provided in the summary. Sector not specified.
20-01-2026
ORION ENERGY SYSTEMS, INC. filed a Form 8-K on January 20, 2026 (AccNo: 0001193125-26-015952, Size: 228 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market, sector not specified. No specific financial metrics, transaction details, or numerical values are disclosed in the provided filing summary.
20-01-2026
Future Vision II Acquisition Corp. filed an 8-K on January 20, 2026 (AccNo: 0001829126-26-000388, Size: 913 KB), disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific parties, deal structure, valuation, or financial metrics are disclosed.
20-01-2026
BioXcel Therapeutics, Inc. filed a Form 8-K on January 20, 2026, reporting under Item 8.01 Other Events. Accession number: 0001104659-26-004787. File size: 186 KB.
20-01-2026
NexMetals Mining Corp. filed a Form 8-K on January 20, 2026 (AccNo: 0001493152-26-002729, Size: 1 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or the specific financial statements/exhibits are provided. Sector is not specified.
20-01-2026
AIM ImmunoTech Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001493152-26-002728, Size: 228 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, financials, or exhibits are provided in the filing summary. Sector not specified.
20-01-2026
Occidental Petroleum Corp /DE/ filed an 8-K on January 20, 2026 (AccNo: 0001628280-26-002483, Size: 234 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific numerical financial metrics, transaction details, or other quantitative data provided in the filing summary. Sector is not specified.
20-01-2026
Novavax Inc filed a Form 8-K on January 20, 2026 (AccNo: 0001104659-26-004785, Size: 199 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's terms, counterparties, transaction value, or financial implications are provided. Sector not specified.
20-01-2026
U.S. GoldMining Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001493152-26-002736, Size: 2 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on voluntary disclosure of potentially material non-public information and attached exhibits. No core event details, transaction values, financial metrics, or other quantitative data are specified.
20-01-2026
Beneficient filed a Form 8-K on January 20, 2026 (AccNo: 0001493152-26-002735, size 290 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosures, events, financial statements, or exhibits are provided in the filing summary. Sector not specified.
20-01-2026
908 Devices Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001104659-26-004798, Size: 173 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US SEC. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.
20-01-2026
Corvus Pharmaceuticals, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001104659-26-004795, Size: 2 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
20-01-2026
AMCON DISTRIBUTING CO filed a Form 8-K on January 20, 2026 (AccNo: 0001104659-26-004794, Size: 379 KB), reporting Results of Operations and Financial Condition under Item 2.02. Item 9.01 includes Financial Statements and Exhibits. No specific financial metrics, transaction values, or other quantitative data disclosed in the provided filing summary.
20-01-2026
AleAnna, Inc. filed a Form 8-K on January 20, 2026 (AccNo: 0001213900-26-005358, Size: 270 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the attached financial statements and exhibits are provided. Sector is not specified.
20-01-2026
SharkNinja, Inc. filed a Form 8-K on 2026-01-20 (AccNo: 0001957132-26-000005, Size: 6 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 48 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC